CommercialCoverageLow impact
Policy Criteria Change
Arkansas Blue Cross Blue Shield·AR · Ophthalmology·Medical Policy
Effective date
Jul 15, 2026
We identified it
Jun 19, 2026
Summary
Arkansas Blue Cross is archiving two medical policies effective July 15, 2026: Transpupillary Thermotherapy for Treatment of Choroidal Neovascularization (Policy 2003036) and Antiprothrombin Antibody (Policy 2003047). Both policies will no longer be active after this date.
Action Required
By July 15, 2026: Billing team should review current claims patterns for transpupillary thermotherapy and antiprothrombin antibody testing to determine if alternative coverage policies will be needed. Verify with Arkansas Blue Cross regarding coverage status for these services after policy archival.